Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin-2 receptor (IL-2R) beta gamma complex refers to the combination of the IL-2 receptor beta (IL-2Rβ, CD122) and common gamma chain (γc, CD132), which together form an intermediate-affinity binding site for interleukin-2 (IL-2). It is crucial for signal transduction, lymphocyte proliferation, and immune homeostasis. Defects can lead to immunodeficiency, while therapeutic targeting is explored for cancer immunotherapy and autoimmune diseases.
Agonist: Promotes receptor dimerization and downstream signaling; Antagonist: Blocks IL-2 binding and signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-2 Receptor Beta Gamma Complex (IL-2Rβγ).